Dextroamphetamine
5 NDCs across 2 manufacturers|1 Generic,4 Brand
Dextroamphetamine is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 22, 2022. In 2024, Medicare Part D spent $200K on Dextroamphetamine across 417 claims for 131 beneficiaries.
Dextroamphetamine is available as 5 NDCs from 2 manufacturers (1 generic, 4 brand), with NADAC prices from $16.23 to $16.26 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
1G / 4B
Manufacturers
2
competing in market
Price Spread
$16.23 – $16.26
per EA, 4 of 5 NDCs
7d Activity
avg +0.6% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Noven Therapeutics, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Central Nervous System Stimulant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing DEXTROAMPHETAMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XELSTRYM 9 MG/9 HR PATCH | $16.2602 per EA | -0.04% |
XELSTRYM 13.5 MG/9 HR PATCH | $16.2585 per EA | -0.06% |
XELSTRYM 4.5 MG/9 HR PATCH | $16.2286 per EA | +0.06% |
XELSTRYM 18 MG/9 HR PATCH | $16.2268 per EA | -0.02% |
DEXTROAMPHETAMINE 5 MG/5 ML | $1.1434 per ML | +2.94% |
Frequently Asked Questions
What is Dextroamphetamine used to treat?
Dextroamphetamine is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Dextroamphetamine?
In 2024, Medicare Part D spent $200K on Dextroamphetamine across 417 claims for 131 beneficiaries.
How many Dextroamphetamine products are on the market?
The Dextroamphetamine drug market contains 5 NDCs from 2 manufacturers — 1 generic and 4 brand products.
What is the price range for Dextroamphetamine?
NADAC reference prices for Dextroamphetamine range from $16.2268 to $16.2602 per EA — a 0% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Dextroamphetamine?
2 manufacturers list Dextroamphetamine in NADAC. Ranked by number of NDCs, the largest are Noven Therapeutics, LLC (4), Cranbury Pharmaceuticals, LLC (1).
How has the price of Dextroamphetamine changed recently?
Over the past 7 days, 2 Dextroamphetamine NDCs rose and 3 fell, with a market-wide average change of +0.6%.